G01N33/57423 - page 3 - CPC Classification Index

#601

20150104815

2015-04-16

Porphyrin-Lipid Stabilized Nanoparticles for Surface Enhanced Raman Scattering Based Imaging

#602

20150098946

2015-04-09

Compositions and methods for the diagnosis and treatment of tumor

#603

20150072895

2015-03-12

SRM/MRM assay for subtyping lung histology

#604

20150072890

2015-03-12

METHODS AND COMPOSITIONS FOR AIDING IN THE DETECTION OF LUNG CANCER

#605

20150072361

2015-03-12

Lung cancer molecular markers

#606

20150065388

2015-03-05

Anti-mesothelin antibodies and immunoconjugates

#607

20150065371

2015-03-05

IMMUNOFLUORESCENCE AND FLUORESCENT-BASED NUCLEIC ACID ANALYSIS ON A SIMGLE SAMPLE

#608

20150064796

2015-03-05

Noninvasive detection of lung cancer using exhaled breath

#609

20150064721

2015-03-05

COMPOSITION AND KIT FOR SEPARATING CANCER CELL, AND METHOD OF SEPARATING CANCER CELL BY USING THE COMPOSITION AND KIT

#610

20150056614

2015-02-26

Devices and methods of cell capture and analysis

#611

20150056252

2015-02-26

Composition and method for diagnosis and immunotherapy of lung cancer

#612

20150038365

2015-02-05

LUNG CANCER BIOMARKERS

#613

20150037820

2015-02-05

LUNG CANCER MARKERS AND USES THEREOF

#614

20150031703

2015-01-29

Methods for detecting FGFR3/TACC3 fusion genes

#615

20150031624

2015-01-29

Anti-mesothelin chimeric antigen receptors

#616

20150031065

2015-01-29

Compositions, methods and kits for diagnosis of lung cancer

#617

20150024399

2015-01-22

MOLECULAR DIAGNOSIS AND TYPING OF LUNG CANCER VARIANTS

#618

20150017210

2015-01-15

Gene Signature Predicts Adenocarcinoma Prognosis and Therapeutic Response

#619

20150011594

2015-01-08

BIN1 expression as a marker of cancer

#620

20150010571

2015-01-08

Anti-RSPO2 antibodies

#621

20150010565

2015-01-08

Anti-RSPO1 antibodies and uses thereof

#622

20150004252

2015-01-01

METHOD FOR PREDICTING THE CLINICAL RESPONSE TO CHEMOTHERAPY IN A SUBJECT WITH CANCER

#623

20140370037

2014-12-18

Anti-DLL3 antibody drug conjugates for treating cancer

#624

20140364593

2014-12-11

Anti-DLL3 antibody drug conjugates

#625

20140364590

2014-12-11

Anti-DLL3 antibodies

#626

20140364326

2014-12-11

COMBINATORIAL BIOMARKERS FOR CLINICAL APPLICATIONS IN LUNG CANCER PATIENT MANAGEMENT

#627

20140363832

2014-12-11

MOLECULAR MARKER FOR THE EARLY DETECTION OF MALIGNANT PLEURAL MESOTHELIOMA AND THE METHODS OF ITS EXPRESSION ANALYSIS USING BLOOD AND PLEURAL EFFUSION SAMPLES

#628

20140363826

2014-12-11

Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies

#629

20140363455

2014-12-11

Anti-DLL3 antibody drug conjugates and methods of use

#630

20140363446

2014-12-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#631

20140357511

2014-12-04

System for isolating cells

#632

20140349399

2014-11-27

Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell

#633

20140349309

2014-11-27

METHODS AND COMPOSITIONS FOR TREATMENT AND DIAGNOSIS OF FIBROSIS, TUMOR INVASION, ANGIOGENESIS, AND METASTASIS

#634

20140341903

2014-11-20

Biological materials related to c-Met

#635

20140341897

2014-11-20

Anti-folate receptor alpha antibodies and uses thereof

#636

20140341802

2014-11-20

PROVASOPRESSIN ANTAGONISTS AND USES THEREOF

#637

20140335535

2014-11-13

PEPTIDE MARKER FOR CANCER DIAGNOSIS AND CANCER DIAGNOSIS METHOD USING THE SAME

#638

20140335022

2014-11-13

Anti-met therapy for previously diagnosed cancer patients

#639

20140296167

2014-10-02

Glycosylation site-specific antibodies and anti-cancer compounds

#640

20140287931

2014-09-25

METHODS AND COMPOSITIONS FOR PREDICTING RESISTANCE TO ANTICANCER TREATMENT

#641

20140287532

2014-09-25

Immunoassay method for pro-gastrin-releasing peptide

#642

20140275073

2014-09-18

Methods of treating cancer sensitive to anti-EGFR therapy and modifying treatment using peroxiredoxin 6 biomarker

#643

20140274772

2014-09-18

Biomarker panel for detecting lung cancer

#644

20140271453

2014-09-18

METHODS FOR THE EARLY DETECTION OF LUNG CANCER

#645

20140255411

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#646

20140255389

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#647

20140248637

2014-09-04

COMPOSITION FOR DIAGNOSIS OF LUNG CANCER AND DIAGNOSIS KIT OF LUNG CANCER

#648

20140242726

2014-08-28

LUNG CANCER MARKER COMPLEMENT C3dg MOLECULE, AND METHOD FOR ANALYZING LUNG CANCER MARKER

#649

20140234327

2014-08-21

Monoclonal antibody against human non-small cell lung carcinoma and use thereof

#650

20140234326

2014-08-21

Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of TM4SF4 in non-small cell lung cancer

#651

20140221404

2014-08-07

Method for determining effectiveness of cancer treatment by assessing the presence of a KIF5B-RET chimeric gene

#652

20140220011

2014-08-07

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#653

20140220006

2014-08-07

LUNG CANCER BIOMARKERS

#654

20140220003

2014-08-07

Therapeutic method for mesothelioma

#655

20140219998

2014-08-07

ARMET AS A MARKER FOR CANCER

#656

20140212896

2014-07-31

Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis

#657

20140200160

2014-07-17

Molecular-based method of cancer diagnosis and prognosis

#658

20140193419

2014-07-10

Methods and compositions for treating and diagnosing diseases

#659

20140170685

2014-06-19

Biomarker of asbestos exposure and mesothelioma

#660

20140170659

2014-06-19

Expression of isoform 202 of ERCC1 for predicting response to cancer chemotherapy

#661

20140154238

2014-06-05

Compositions and methods for treating, diagnosing and monitoring disease

#662

20140120528

2014-05-01

Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome

#663

20140106375

2014-04-17

Secreted tumor-associated cytochrome as a blood-based biomarker for cancer

#664

20140066329

2014-03-06

LUNG CANCER DIAGNOSTIC ASSAY

#665

20140024553

2014-01-23

Methods of identification and diagnosis of lung diseases using classification systems and kits thereof

#666

20130338214

2013-12-19

Method for suppressing receptor tyrosine kinase-mediated pro-survival signaling in cancer cell

#667

20130324705

2013-12-05

LOX and LOXL2 inhibitors and uses thereof

#668

20130288272

2013-10-31

Lung cancer differential marker

#669

20130288241

2013-10-31

Compositions and methods for detecting a neoplasia

#670

20130280246

2013-10-24

Humanized antibodies with anti-tumor activity

#671

20130260388

2013-10-03

Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof

#672

20130259877

2013-10-03

Reagents, methods, and kits for the classification of cancer

#673

20130259865

2013-10-03

Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof

#674

20130230877

2013-09-05

Compositions, methods and kits for diagnosis of lung cancer

#675

20130217057

2013-08-22

Compositions, methods and kits for diagnosis of lung cancer

#676

20130183317

2013-07-18

G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker

#677

20130183299

2013-07-18

Anti-folate receptor alpha antibodies and uses thereof

#678

20130177936

2013-07-11

Method of cancer diagnosis using the analysis of isotopes

#679

20130171258

2013-07-04

Pharmaceutical composition for elevating radio-sensitivity of cancer cells, pharmaceutical composition for detecting cancer cells with radio-sensitivity, and detection method thereof

#680

20130149711

2013-06-13

BARD1 isoforms in lung and colorectal cancer and use thereof

#681

20130149389

2013-06-13

Biomarkers of lung function

#682

20130149388

2013-06-13

Metabolomics-based biomarkers for lung function

#683

20130143247

2013-06-06

Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer

#684

20130136755

2013-05-30

MLK4 gene, a new diagnostic and prognostic marker in cancers

#685

20130123472

2013-05-16

MAGE antigen binding proteins

#686

20130095490

2013-04-18

COMPOSITION FOR DIAGNOSIS OF LUNG CANCER AND DIAGNOSIS KIT OF LUNG CANCER

#687

20130064827

2013-03-14

IL-17 HOMOLOGOUS POLYPEPTIDES AND THEREAPEUTIC USES THEREOF

#688

20130059747

2013-03-07

Multigene prognostic assay for lung cancer

#689

20130059742

2013-03-07

GLOBAL ANALYSIS OF SERUM MICRO RNAS AS POTENTIAL BIOMARKERS FOR LUNG ADENOCARCINOMA

#690

20130059305

2013-03-07

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#691

20130059304

2013-03-07

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#692

20130052207

2013-02-28

Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary Adenocarcinoma

#693

20130039909

2013-02-14

Predicting response to a HER inhibitor

#694

20130034565

2013-02-07

Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases

#695

20130029357

2013-01-31

Diagnostic marker for effect of anticancer agent

#696

20130017963

2013-01-17

Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)

#697

20130017195

2013-01-17

Anti-folate receptor alpha antibodies and uses thereof

#698

20130013334

2013-01-10

Methods for the identification, assessment, and treatment of patients with cancer therapy

#699

20130011496

2013-01-10

CANCER TESTIS ANTIGENS AS BIOMARKERS IN NON-SMALL CELL LUNG CANCER

#700

20130005678

2013-01-03

Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate

#701

20120329669

2012-12-27

Use of DKK-1 protein in the cancer diagnosis

#702

20120323594

2012-12-20

PROGNOSTIC AND PREDICTIVE GENE SIGNATURE FOR NON-SMALL CELL LUNG CANCER AND ADJUVANT CHEMOTHERAPY

#703

20120322075

2012-12-20

Lung Tumor Markers and Methods of Use Thereof

#704

20120322071

2012-12-20

Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma

#705

20120315641

2012-12-13

Protein Markers for Lung Cancer Detection and Methods of Using Thereof

#706

20120302729

2012-11-29

Hybridomas producing monoclonal anti-mortalin peptide antibodies

#707

20120302624

2012-11-29

Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients

#708

20120302455

2012-11-29

Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof

#709

20120295932

2012-11-22

METHOD FOR THE TREATMENT OF CANCER

#710

20120295878

2012-11-22

METHOD FOR THE TREATMENT OF CANCER

#711

20120295803

2012-11-22

LUNG CANCER SIGNATURE

#712

20120282631

2012-11-08

METHOD FOR DIAGNOSIS NON-SMALL-CELL-LUNG-CARCINOMA (NSCLC) AND CLASSIFICATION OF ITS SUBTYPES WITH DIFFERENT COMBINATIONS OF 6 PROTEIN BIOMARKERS

#713

20120277110

2012-11-01

PARP AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER

#714

20120276552

2012-11-01

SERUM SPLA2-IIA AS DIAGNOSIS MARKER FOR PROSTATE AND LUNG CANCER

#715

20120269732

2012-10-25

Methods of controlling tumorigenesis and diagnosing the risk thereof

#716

20120264164

2012-10-18

Lymph node specimen collection kit and method of pathological analysis for lung cancer diagnosis using such a kit

#717

20120258878

2012-10-11

PROGNOSTIC GENE SIGNATURES FOR NON-SMALL CELL LUNG CANCER

#718

20120252039

2012-10-04

Plasma kallikrein fragments as diagnostic biomarkers for lung cancers

#719

20120245051

2012-09-27

OBJECTIVE, QUANTITATIVE METHOD TO PREDICT HISTOLOGICAL SUBTYPE IN NON-SMALL CELL LUNG CANCER

#720

20120237937

2012-09-20

METHODS TO DETECT CANCER IN ANIMALS

#721

20120231966

2012-09-13

LUNG CANCER DIAGNOSTIC ASSAY

#722

20120225954

2012-09-06

METHODS AND COMPOSITIONS FOR THE CLASSIFICATION OF NON-SMALL CELL LUNG CARCINOMA

#723

20120225013

2012-09-06

Anti-mesothelin antibodies and immunoconjugates

#724

20120219570

2012-08-30

G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker

#725

20120214828

2012-08-23

DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS

#726

20120214169

2012-08-23

DIFFERENTIAL LEVELS OF HAPTOGLODIN ISOFORMS IN SMALL CELL LUNG CANCER

#727

20120208824

2012-08-16

ROS Kinase in Lung Cancer

#728

20120208770

2012-08-16

Carcinoma homing peptide (CHP), its analogs, and methods of using

#729

20120207771

2012-08-16

FOLATE RECEPTOR ALPHA AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR FOLATE RECEPTOR ALPHA-EXPRESSING CANCERS

#730

20120201837

2012-08-09

Use of eIF3m for the diagnosis and treatment of cancer

#731

20120196303

2012-08-02

CYBP as a marker for lung cancer

#732

20120190573

2012-07-26

BIOMARKER OF LUNG CANCER

#733

20120190567

2012-07-26

DIAGNOSTIC AND PROGNOSTIC METHODS FOR LUNG DISORDERS USING GENE EXPRESSION PROFILES FROM NOSE EPITHELIAL CELLS

#734

20120190563

2012-07-26

METHODS FOR PREDICTING SENSITIVITY TO TREATMENT WITH A TARGETED TYROSINE KINASE INHIBITOR

#735

20120178111

2012-07-12

METHODS AND COMPOSITIONS FOR THE DETECTION OF LUNG CANCERS

#736

20120178093

2012-07-12

Methods of assessing a risk of cancer progression

#737

20120177659

2012-07-12

Methods and compositions for treating and diagnosing diseases

#738

20120171225

2012-07-05

Diagnostic Method for Predicting the Risk of Cancer Recurrence Based on Histone Macroh2A Isoforms

#739

20120157465

2012-06-21

DNA methylation inhibitors

#740

20120157335

2012-06-21

Flap Endonuclease-1 As A Marker For Cancer

#741

20120149586

2012-06-14

METHODS OF PREDICTING THE RISK OF RECURRENCE OF CANCER

#742

20120143805

2012-06-07

Cancer Biomarkers and Uses Thereof

#743

20120142558

2012-06-07

Diagnostic lung cancer panel and methods for its use

#744

20120141579

2012-06-07

Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer

#745

20120134997

2012-05-31

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#746

20120129869

2012-05-24

PHOSPHORYLATION AND MUTATIONS OF ANAPLASTIC LYMPHOMA KINASE AS A DIAGNOSTIC AND THERAPEUTIC TARGET IN LUNG CANCER

#747

20120129191

2012-05-24

COCKTAIL ANTIBODY, DETERMINATION KIT AND DETERMINATION METHOD FOR DETERMINING HISTOLOGICAL TYPE OF CARCINOMA

#748

20120128678

2012-05-24

Diagnosis and treatment of cancer using anti-TMPRSS11E antibody

#749

20120128587

2012-05-24

FOLATE-TARGETED DIAGNOSTICS AND TREATMENT

#750

20120122841

2012-05-17

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

#751

20120122718

2012-05-17

BRM Expression and Related Diagnostics

#752

20120122112

2012-05-17

ANTIBODIES AS A CANCER DIAGNOSTIC

#753

20120115745

2012-05-10

METHODS FOR PREDICTING SENSITIVITY TO TREATMENT WITH A TARGETED TYROSINE KINASE INHIBITOR

#754

20120101002

2012-04-26

Lung Cancer Biomarkers and Uses Thereof

#755

20120100999

2012-04-26

PROGNOSTIC GENE EXPRESSION SIGNATURE FOR SQUAMOUS CELL CARCINOMA OF THE LUNG

#756

20120100558

2012-04-26

LUNG CANCER DIAGNOSIS

#757

20120100538

2012-04-26

Devices and methods of cell capture and analysis

#758

20120100147

2012-04-26

Anti-KTPAF50 antibodies and their uses in therapeutic and diagnostic methods

#759

20120095029

2012-04-19

IPP COMPLEX AS MARKER FOR ERLOTINIB TREATMENT

#760

20120094311

2012-04-19

Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors

#761

20120094291

2012-04-19

FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME

#762

20120093837

2012-04-19

Compositions and methods for detecting EGFR in cancer

#763

20120089541

2012-04-12

BIOMARKERS AND METHODS OF TREATMENT

#764

20120087917

2012-04-12

LOX AND LOXL2 INHIBITORS AND USES THEREOF

#765

20120083503

2012-04-05

Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer

#766

20120082993

2012-04-05

DETECTING CANCER WITH ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES

#767

20120076725

2012-03-29

Lung cancer markers, and uses thereof

#768

20120076724

2012-03-29

Serpentine transmembrane antigens expressed in human cancers and uses thereof

#769

20120071334

2012-03-22

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

#770

20120064102

2012-03-15

PEPTIDE INDUCING XAGE-1B-SPECIFIC IMMUNE REACTION AND UTILIZATION OF SAME

#771

20120064073

2012-03-15

IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

#772

20120058909

2012-03-08

IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

#773

20120058131

2012-03-08

PTA089 PROTEIN

#774

20120053225

2012-03-01

AKT tyrosine 176 phosphorylation cancer biomarker

#775

20120052071

2012-03-01

TUMOR MARKERS AND METHODS OF USE THEREOF

#776

20120045770

2012-02-23

Lung tissue model

#777

20120045439

2012-02-23

Tumor markers and methods of use thereof

#778

20120040383

2012-02-16

Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer

#779

20120040376

2012-02-16

Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect

#780

20120040021

2012-02-16

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#781

20120028279

2012-02-02

BIOMARKER FOR MONITORING PATIENTS

#782

20120015847

2012-01-19

Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3

#783

20120010266

2012-01-12

TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER

#784

20120004117

2012-01-05

Diagnosis and treatment of cancer using anti-TM4SF20 antibody

#785

20120004116

2012-01-05

METHODS FOR BIOMARKER IDENTIFICATION AND BIOMARKER FOR NON-SMALL CELL LUNG CANCER

#786

20110319289

2011-12-29

Molecular-based method of cancer diagnosis and prognosis

#787

20110319280

2011-12-29

ECT2 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND ESOPHAGEAL CANCER

#788

20110318336

2011-12-29

Identification and Treatment of Aggressive Lung Cancer Tumors

#789

20110318308

2011-12-29

LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE AS A BIOMARKER FOR LUNG CANCER PROGRESSION AND PROGNOSIS

#790

20110301095

2011-12-08

METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING METASTASIS, METASTATIC CANCER, AND POTENTIAL FOR METASTASIS

#791

20110301056

2011-12-08

NECTIN-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS

#792

20110287034

2011-11-24

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

#793

20110281279

2011-11-17

CIRCULATING Epha2 RECEPTOR

#794

20110277538

2011-11-17

Volatile organic compounds as diagnostic markers in the breath for lung cancer

#795

20110275100

2011-11-10

Serpin B 13 as a marker for squamous cell carcinoma of the lung

#796

20110275097

2011-11-10

Drug selection for lung cancer therapy using antibody-based arrays

#797

20110269948

2011-11-03

Method for identifying compounds for cancer therapy

#798

20110269774

2011-11-03

PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK

#799

20110269632

2011-11-03

Detection of cancer through breath comprising a sensor array comprising capped conductive nanoparticles

#800

20110269171

2011-11-03

METHODS AND MATERIALS FOR USING NKAP POLYPEPTIDE EXPRESSION LEVELS OR PATTERNS TO DETECT OR ASSESS CANCER

#801

20110263012

2011-10-27

SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX

#802

20110262929

2011-10-27

Anti-HS6ST2 antibodies and uses thereof

#803

20110262463

2011-10-27

SYNGR4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS

#804

20110256539

2011-10-20

Methods for Detecting Tumor Origin Based on MUC1, MUC2, and CK-17 Expression Levels

#805

20110256241

2011-10-20

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#806

20110251098

2011-10-13

Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers

#807

20110251077

2011-10-13

Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples

#808

20110246399

2011-10-06

PREDICTING RESPONSE TO A HER INHIBITOR

#809

20110245103

2011-10-06

PREDICTING RESPONSE TO A HER INHIBITOR

#810

20110237461

2011-09-29

USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE

#811

20110224313

2011-09-15

COMPOSITIONS AND METHODS FOR CLASSIFYING LUNG CANCER AND PROGNOSING LUNG CANCER SURVIVAL

#812

20110224159

2011-09-15

BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS

#813

20110223623

2011-09-15

METHODS FOR DIAGNOSING CANCER AND DETERMINING THE OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL OF CANCER PATIENTS

#814

20110223609

2011-09-15

Gene defects and mutant ALK kinase in human solid tumors

#815

20110219464

2011-09-08

LUNG DISEASE TARGETS AND USES THEREOF

#816

20110217717

2011-09-08

DIAGNOSTIC AND PROGNOSTIC METHODS FOR LUNG DISORDERS USING GENE EXPRESSION PROFILES FROM NOSE EPITHELIAL CELLS

#817

20110217701

2011-09-08

Prognostic Marker for Endometrial Carcinoma

#818

20110212472

2011-09-01

Asbestos Exposure, Pleural Mesothelioma and Osteopontin Levels

#819

20110212465

2011-09-01

ARMET as a marker for cancer

#820

20110212464

2011-09-01

PACAP AS A MARKER FOR CANCER

#821

20110212095

2011-09-01

Epitope of CD66C specific to lung adenocarcinoma and antibody recognizing the same

#822

20110212085

2011-09-01

LUNG CANCER DISEASE TARGETS AND USES THEREOF

#823

20110207743

2011-08-25

PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK

#824

20110207622

2011-08-25

Salivary biomarkers for lung cancer detection

#825

20110201517

2011-08-18

AUTOANTIGEN BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG ADENOCARCINOMA

#826

20110200608

2011-08-18

Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof

#827

20110195923

2011-08-11

Methods for predicting the response to anti-cancer treatment with an agonist of TLR7 or an agonist of TLR8

#828

20110195447

2011-08-11

Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha

#829

20110195133

2011-08-11

Dermcidin-derived peptides for lung cancer diagnostics

#830

20110189691

2011-08-04

Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors

#831

20110177533

2011-07-21

Asbestos exposure, pleural mesothelioma, and osteopontin levels

#832

20110171676

2011-07-14

ASC as a marker for lung cancer

#833

20110167505

2011-07-07

GFATS As Modifiers of the AXIN Pathway and Methods of Use

#834

20110152345

2011-06-23

EBI3, DLX5, NPTX1 AND CDKN3 FOR TARGET GENES OF LUNG CANCER THERAPY AND DIAGNOSIS

#835

20110137016

2011-06-09

Compositions and methods for the diagnosis and treatment of tumor

#836

20110136119

2011-06-09

AIMP2-DX2 gene and its uses

#837

20110119776

2011-05-19

METHODS OF DIAGNOSING AND PROGNOSING LUNG CANCER

#838

20110117572

2011-05-19

Antibody Specific to the AIMP2-DX2

#839

20110105341

2011-05-05

Diagnostic methods for determining prognosis of non-small cell lung cancer

#840

20110104680

2011-05-05

RECURRENT GENE FUSIONS IN LUNG CANCER

#841

20110097756

2011-04-28

APEX AS A MARKER FOR LUNG CANCER

#842

20110082089

2011-04-07

BIOMARKERS FOR MONITORING OR PREDICTING THE TREATMENT OF CANCER

#843

20110070652

2011-03-24

Phage microarray profiling of the humoral response to disease

#844

20110064739

2011-03-17

MEDICAMENT, COMPOSITIONS, AND SUBSTANCES FOR TREATING AND IDENTIFYING ADENOCARCINOMA OF THE LUNG

#845

20110053156

2011-03-03

SMALL CELL LUNG CARCINOMA BIOMARKER PANEL

#846

20110044906

2011-02-24

Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer

#847

20110038801

2011-02-17

METHODS AND COMPOSITIONS FOR IDENTIFYING LUNG CANCER OR A HUMORAL IMMUNE RESPONSE AGAINST LUNG CANCER

#848

20110038800

2011-02-17

Method for the treatment of lymphangioleiomyomatosis (LAM)

#849

20110027283

2011-02-03

Methods for diagnosing and treating cancers

#850

20110021546

2011-01-27

Gene defects and mutant ALK kinase in human solid tumors

#851

20110014647

2011-01-20

System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP)

#852

20110014615

2011-01-20

METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8

#853

20110014231

2011-01-20

ANTI-MEASLES CANCER IMMUNOTHERAPY

#854

20110014214

2011-01-20

Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers

#855

20110009473

2011-01-13

PTTG1 as a biomarker for cancer treatment

#856

20110003017

2011-01-06

Method for Preparation of Extract from Angelica Gigas Nakai and Composition Containing the Extract

#857

20100331203

2010-12-30

AROMATASE EXPRESSION PREDICTS SURVIVAL IN WOMEN WITH NON-SMALL CELL LUNG CANCER

#858

20100330587

2010-12-30

Annexin proteins and autoantibodies as serum markers for cancer

#859

20100325743

2010-12-23

Marks as modifiers of the p53 pathway and methods of use

#860

20100317098

2010-12-16

Nucleic acid molecules encoding soluble frizzled (FZD) receptors

#861

20100304989

2010-12-02

Molecular profiling of tumors

#862

20100304382

2010-12-02

Gene defects and mutant ALK kinase in human solid tumors

#863

20100298404

2010-11-25

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#864

20100297134

2010-11-25

Humanised antibodies with anti-tumour activity

#865

20100292162

2010-11-18

SOCS-3 promoter methylation in cancer

#866

20100291091

2010-11-18

CANCER ASSOCIATED GENE LY6K

#867

20100285507

2010-11-11

PLASMA KALLIKREIN FRAGMENTS AS DIAGNOSTIC BIOMARKERS FOR LUNG CANCERS

#868

20100284918

2010-11-11

PROTEIN

#869

20100273191

2010-10-28

Methods of diagnosing cancer

#870

20100272635

2010-10-28

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN OVARIAN CANCER AND LUNG CANCER

#871

20100255486

2010-10-07

Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells

#872

20100248290

2010-09-30

Methods for detecting lung cancer and monitoring treatment response

#873

20100248234

2010-09-30

Cancer diagnostic kit and cancer diagnostic method

#874

20100240546

2010-09-23

USE OF BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER

#875

20100240081

2010-09-23

Method for providing diagnosis of cancer using seprase as a marker

#876

20100240031

2010-09-23

Method of predicting metastatic potential prognosis or overall survival of cancer patients

#877

20100239615

2010-09-23

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER

#878

20100235927

2010-09-16

Non-human animal model for lung carcinoma

#879

20100233703

2010-09-16

EMX2 in cancer diagnosis and prognosis

#880

20100233695

2010-09-16

Molecular diagnosis and typing of lung cancer variants

#881

20100221744

2010-09-02

Method for prediction of postoperative prognosis and diagnosis kit

#882

20100216718

2010-08-26

Cancer Classification and Methods of Use

#883

20100196931

2010-08-05

DETERMINATION OF RESPONDERS TO CHEMOTHERAPY

#884

20100184063

2010-07-22

PROGNOSTIC AND PREDICTIVE GENE SIGNATURE FOR NON-SMALL CELL LUNG CANCER AND ADJUVANT CHEMOTHERAPY

#885

20100184047

2010-07-22

SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX

#886

20100184021

2010-07-22

NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND METHODS OF USE THEREOF FOR DIAGNOSIS

#887

20100183506

2010-07-22

ANTIGEN ASSOCIATED WITH LUNG CANCERS AND LYMPHOMAS

#888

20100179067

2010-07-15

SERUM BIOMARKERS FOR THE EARLY DETECTION OF LUNG CANCER

#889

20100167297

2010-07-01

METHOD OF DETERMINING THE TIME TO PROGRESSION OF NON SMALL CELL LUNG CANCER AFTER CHEMOTHERAPY BASED ON THIOREDOXIN EXPRESSION

#890

20100167296

2010-07-01

METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIME AND SURVIVAL EXPECTANCY FOR NON SMALL CELL LUNG CANCER BASED ON EGFR/CSF-1/CA IX EXPRESSION

#891

20100159470

2010-06-24

SCDs as modifiers of the p53 pathway and methods of use

#892

20100152058

2010-06-17

Cancer markers

#893

20100150907

2010-06-17

PRO115 antibody compositions and methods of use

#894

20100150901

2010-06-17

26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor

#895

20100143918

2010-06-10

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#896

20100136711

2010-06-03

IMMUNOASSAY METHOD FOR PRO-GASTRIN-RELEASING PEPTIDE

#897

20100136139

2010-06-03

Cancer marker and therapeutic agent for cancer

#898

20100136017

2010-06-03

Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer

#899

20100113475

2010-05-06

PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK

#900

20100112626

2010-05-06

Use of Semenogelin in the Diagnosis, Prognosis and Treatment of Cancer